Abstract

Severe acute respiratory syndrome coronavirus (SARS-COV-2) presented with pulmonary symptoms and various extra pulmonary manifestations including dermatological manifestations like urticarial, acralvascular lesion erythematous maculopapular rash, and vesicular rash. Herpes zoster is a painful vesicular rash resulting from reactivation of varicella-zoster (VZ) virus that also a causative agent of chickenpox. The incidence of HZ infection (HZI) more prevalent in older ages and various immunosuppressive conditions. Coronavirus disease in 2019(Covid19) causing immune exhaustion and VZ virus reactivation, which is commonly presented as HZ in middle-aged adults. Here we report a case of HZ infection in association with COVID 19 positive 60 years male. Update Dent. Coll. j: 2021; 11(2): 35-37

Highlights

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) was identified in December 2019 as the cause of COVID-19 in Wuhan City in Hubei Province, China [1]

  • Cell entry is believed to be through the angiotensin-converting enzyme 2 (ACE2) receptors found on the surface of the cells [4]

  • Reactivation of HZ is infrequent in covid-19 patients, but few cases raised the concerns of the possible association

Read more

Summary

INTRODUCTION

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) was identified in December 2019 as the cause of COVID-19 in Wuhan City in Hubei Province, China [1]. The COVID-19 screening test was arranged and the patient was treated symptomatically and advised for home isolation The day, his nasopharyngeal swab for rt-PCR turned positive for SARS-CoV2, and the patient was advised for supervised treatment. HRCT of the chest shows multi-focal groundglass opacities, interlobular thickening with crazy paving appearance involving a different segment of both lungs He was treated with board spectrum antibiotic, LMWH, Montelukast and bronchodilator for Covid pneumonia for HZ, he was prescribed valaciclovir 1gm TDS for 7 days. Since starting medication his respiratory symptoms and HZ rash significantly improved with residual pain at the HZ site

DISCUSSION
CONCLUSION
Cohen JI
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.